Adage Capital Partners’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-225,000
| Closed | -$8.52M | – | 778 |
|
|
2019
Q2 | $8.52M | Buy |
225,000
+58,000
| +35% | +$2.2M | 0.02% | 550 |
|
|
2019
Q1 | $6.52M | Buy |
+167,000
| New | +$6.52M | 0.02% | 584 |
|
|
2018
Q2 | – | Sell |
-225,000
| Closed | -$6.76M | – | 815 |
|
|
2018
Q1 | $6.76M | Sell |
225,000
-525,000
| -70% | -$15.8M | 0.02% | 612 |
|
|
2017
Q4 | $23.4M | Sell |
750,000
-1,150,000
| -61% | -$35.9M | 0.05% | 366 |
|
|
2017
Q3 | $53.2M | Hold |
1,900,000
| – | – | 0.13% | 212 |
|
|
2017
Q2 | $36.3M | Buy |
1,900,000
+1,287,489
| +210% | +$24.6M | 0.09% | 295 |
|
|
2017
Q1 | $10.4M | Buy |
612,511
+170,511
| +39% | +$2.91M | 0.03% | 529 |
|
|
2016
Q4 | $8.08M | Hold |
442,000
| – | – | 0.02% | 556 |
|
|
2016
Q3 | $7.87M | Buy |
+442,000
| New | +$7.87M | 0.02% | 558 |
|